AAAAAA

   
Results: 1-18 |
Results: 18
REDUCED DOSE OF SUBCUTANEOUS CLADRIBINE INDUCES IDENTICAL RESPONSE RATES BUT DECREASED TOXICITY IN PRETREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BETTICHER DC RATSCHILLER D SCHMITZ SFH VONROHR A HESS U ZULIAN G WERNLI M TICHELLI A TOBLER A FEY MF CERNY T
Citation: Dc. Betticher et al., REDUCED DOSE OF SUBCUTANEOUS CLADRIBINE INDUCES IDENTICAL RESPONSE RATES BUT DECREASED TOXICITY IN PRETREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of oncology, 9(7), 1998, pp. 721-726
FEWER INFECTIONS, BUT MAINTAINED ANTITUMOR-ACTIVITY WITH LOWER-DOSE VERSUS STANDARD-DOSE CLADRIBINE IN PRETREATED LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: BETTICHER DC VONROHR A RATSCHILLER D SCHMITZ SFH EGGER T SONDEREGGER T HERRMANN R KRONER T ZULIAN GB CAVALLI F FEY MF CERNY T
Citation: Dc. Betticher et al., FEWER INFECTIONS, BUT MAINTAINED ANTITUMOR-ACTIVITY WITH LOWER-DOSE VERSUS STANDARD-DOSE CLADRIBINE IN PRETREATED LOW-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(3), 1998, pp. 850-858
2-CDA IN THE TREATMENT OF HAIRY-CELL LEUKEMIA - INTRAVENOUS VS SUBCUTANEOUS ADMINISTRATION
Authors: SPERB RA VONROHR A RATSCHILLER D BACCHI M TICHELLI A HESS U CERNY T TOBLER A BETTICHER DC
Citation: Ra. Sperb et al., 2-CDA IN THE TREATMENT OF HAIRY-CELL LEUKEMIA - INTRAVENOUS VS SUBCUTANEOUS ADMINISTRATION, Schweizerische medizinische Wochenschrift, 128(42), 1998, pp. 1593-1597
ON THE CURRENT STATE OF WEAPONS STUDIES - SPEECH HELD IN DRESDEN, OCTOBER 4, 1996
Authors: VONROHR A
Citation: A. Vonrohr, ON THE CURRENT STATE OF WEAPONS STUDIES - SPEECH HELD IN DRESDEN, OCTOBER 4, 1996, Waffen- und Kostumkunde, 39(1-2), 1997, pp. 1-3
CLADRIBINE (2-CDA) GIVEN AS SUBCUTANEOUS BOLUS INJECTIONS IS ACTIVE IN PRETREATED WALDENSTROMS MACROGLOBULINEMIA
Authors: BETTICHER DC SCHMITZ SFH RATSCHILLER D VONROHR A EGGER T PUGIN P STALDER M HESS U FEY MF CERNY T
Citation: Dc. Betticher et al., CLADRIBINE (2-CDA) GIVEN AS SUBCUTANEOUS BOLUS INJECTIONS IS ACTIVE IN PRETREATED WALDENSTROMS MACROGLOBULINEMIA, British Journal of Haematology, 99(2), 1997, pp. 358-363
CLONAL ANALYSIS OF A B-CELL LYMPHOMA WITH RECURRENT SPONTANEOUS REMISSIONS AND EVOLUTION INTO CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: NAGEL S BORISCH B VONROHR A TOBLER A FEY MF
Citation: S. Nagel et al., CLONAL ANALYSIS OF A B-CELL LYMPHOMA WITH RECURRENT SPONTANEOUS REMISSIONS AND EVOLUTION INTO CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of oncology, 7(9), 1996, pp. 953-960
2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH FOLLICULAR STAGE III-IV NON-HODGKINS-LYMPHOMA
Authors: BETTICHER DC ZUCCA E VONROHR A EGGER T RADFORD JA AMBROSETTI A BURKI K RUFENER B SCHMITZ SFH CERNY T
Citation: Dc. Betticher et al., 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH FOLLICULAR STAGE III-IV NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(8), 1996, pp. 793-799
THE NUMBER OF CIRCULATING CD34(-CELLS PREDICTS THE COLONY-FORMING CAPACITY OF LEUKAPHERESIS PRODUCTS IN CHILDREN() BLOOD)
Authors: LEIBUNDGUT K VONROHR A BRULHART K HIRT A ISCHI E JEANNERET C MUFF J LUTHY AR WAGNER HP TOBLER A
Citation: K. Leibundgut et al., THE NUMBER OF CIRCULATING CD34(-CELLS PREDICTS THE COLONY-FORMING CAPACITY OF LEUKAPHERESIS PRODUCTS IN CHILDREN() BLOOD), Bone marrow transplantation, 15(1), 1995, pp. 25-31
2-CHLORODEOXYADENOSINE (CDA) BY SUBCUTANEOUS BOLUS INJECTION - A PHASE-II STUDY IN HAIRY-CELL LEUKEMIA (HCL)
Authors: VONROHR A BACCHI M FEY MF HESS U TICHELLI A PIGUET D FRICKHOFEN N SCHIRMER M WERNLI M ZULIAN G MARINI G CERNY T TOBLER A
Citation: A. Vonrohr et al., 2-CHLORODEOXYADENOSINE (CDA) BY SUBCUTANEOUS BOLUS INJECTION - A PHASE-II STUDY IN HAIRY-CELL LEUKEMIA (HCL), Blood, 86(10), 1995, pp. 1386-1386
HIGH-INCIDENCE OF INFECTIONS AFTER 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMAS AND CHRONIC AND ACUTE LEUKEMIAS
Authors: BETTICHER DC FEY MF VONROHR A TOBLER A JENZER H GRATWOHL A LOHRI A PUGIN P HESS U PAGANI O ZULIAN G CERNY T
Citation: Dc. Betticher et al., HIGH-INCIDENCE OF INFECTIONS AFTER 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PATIENTS WITH MALIGNANT-LYMPHOMAS AND CHRONIC AND ACUTE LEUKEMIAS, Annals of oncology, 5(1), 1994, pp. 57-64
VALUE OF BONE-MARROW FOLLOW-UP EXAMINATIO N ON DAY-A AND DAY-17 OF THE FIRST INDUCTION COURSE IN ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: ZINGG K VONROHR A FEY MF TOBLER A
Citation: K. Zingg et al., VALUE OF BONE-MARROW FOLLOW-UP EXAMINATIO N ON DAY-A AND DAY-17 OF THE FIRST INDUCTION COURSE IN ACUTE MYELOGENOUS LEUKEMIA (AML), Schweizerische medizinische Wochenschrift, 124(1-2), 1994, pp. 51-55
INTERPRETATION OF X-CHROMOSOME INACTIVATION PATTERNS - RESPONSE
Authors: FEY MF VONROHR A TOBLER A
Citation: Mf. Fey et al., INTERPRETATION OF X-CHROMOSOME INACTIVATION PATTERNS - RESPONSE, Blood, 84(7), 1994, pp. 2377-2378
THE LIMIT OF DOSE-INTENSIFICATION IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA DESPITE GROWTH-FACTOR THERAPY
Authors: WERNLI M FEY MF TOBLER A VONROHR A BARGETZI M TICHELLI A FEHR J GMUR J JACKY E BERIS P CHAPUIS B HESS U DELACRETAZ F JOTTERAND M SCHAPIRA M CAVALLI F MAIBACH R RUFENER B GRATWOHL A
Citation: M. Wernli et al., THE LIMIT OF DOSE-INTENSIFICATION IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA DESPITE GROWTH-FACTOR THERAPY, Blood, 84(10), 1994, pp. 10000144-10000144
2-CHLORODEOXYADENOSINE (CDA) BY SUBCUTANEOUS BOLUS INJECTION - A PHASE-II STUDY IN HAIRY-CELL LEUKEMIA (HCL)
Authors: VONROHR A FEY MF CERNY T WERNLI M PIGUET D TICHELLI A ZULIAN G BACCHI M TOBLER A
Citation: A. Vonrohr et al., 2-CHLORODEOXYADENOSINE (CDA) BY SUBCUTANEOUS BOLUS INJECTION - A PHASE-II STUDY IN HAIRY-CELL LEUKEMIA (HCL), Blood, 84(10), 1994, pp. 10000462-10000462
PERIPHERAL-BLOOD LYMPHOCYTE (PBL) SUBPOPULATIONS IN PATIENTS TREATED WITH 2-CHLORODEOXYADENOSINE (CDA) - CORRELATION WITH INFECTION-RATE
Authors: VONROHR A BETTICHER D CERNY T FEY MF TOBLER A
Citation: A. Vonrohr et al., PERIPHERAL-BLOOD LYMPHOCYTE (PBL) SUBPOPULATIONS IN PATIENTS TREATED WITH 2-CHLORODEOXYADENOSINE (CDA) - CORRELATION WITH INFECTION-RATE, Blood, 84(10), 1994, pp. 10000598-10000598
CLONALITY AND X-INACTIVATION PATTERNS IN HEMATOPOIETIC-CELL POPULATIONS DETECTED BY THE HIGHLY INFORMATIVE M27-BETA DNA-PROBE
Authors: FEY MF LIECHTIGALLATI S VONROHR A BORISCH B THEILKAS L SCHNEIDER V OESTREICHER M NAGEL S ZIEMIECKI A TOBLER A
Citation: Mf. Fey et al., CLONALITY AND X-INACTIVATION PATTERNS IN HEMATOPOIETIC-CELL POPULATIONS DETECTED BY THE HIGHLY INFORMATIVE M27-BETA DNA-PROBE, Blood, 83(4), 1994, pp. 931-938
X-INACTIVATION IN HEMATOPOIETIC-CELL POPULATIONS DETECTED BY THE M27-BETA DNA-PROBE
Authors: FEY MF LIECHTIGALLATI S BORISCH B THEILKAS L SCHNEIDER V OESTREICHER M VONROHR A TOBLER A
Citation: Mf. Fey et al., X-INACTIVATION IN HEMATOPOIETIC-CELL POPULATIONS DETECTED BY THE M27-BETA DNA-PROBE, Experimental hematology, 21(8), 1993, pp. 1160-1160
SERIAL IMMUNOPHENOTYPE ANALYSIS OF PERIPHERAL-BLOOD T-CELLS, T-CELL SUBPOPULATIONS, B-CELLS, AND NATURAL-KILLER (NK) CELLS IN PATIENTS TREATED WITH 2-CHLORODEOXYADENOSINE (2-CDA)
Authors: VONROHR A BETTICHER D CERNY T JEANNERET C WERNLI M TICHELLI A FEY MF TOBLER A
Citation: A. Vonrohr et al., SERIAL IMMUNOPHENOTYPE ANALYSIS OF PERIPHERAL-BLOOD T-CELLS, T-CELL SUBPOPULATIONS, B-CELLS, AND NATURAL-KILLER (NK) CELLS IN PATIENTS TREATED WITH 2-CHLORODEOXYADENOSINE (2-CDA), Blood, 82(10), 1993, pp. 10000521-10000521
Risultati: 1-18 |